Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9PJY
|
||||
| Drug Name |
{1-[3-(2-Benzyloxycarbonylamino-4-methyl-pentanoylamino)-4-oxo-pyrrolidine-1-carbonyl]-3-methyl-butyl}-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL29483
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C32H42N4O7
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N2CC(NC(=O)[C@@H](CC(C)C)NC(=O)OCc3ccccc3)C(=O)C2
|
||||
| InChI |
InChI=1S/C32H42N4O7/c1-21(2)15-25(34-31(40)42-19-23-11-7-5-8-12-23)29(38)33-27-17-36(18-28(27)37)30(39)26(16-22(3)4)35-32(41)43-20-24-13-9-6-10-14-24/h5-14,21-22,25-27H,15-20H2,1-4H3,(H,33,38)(H,34,40)(H,35,41)/t25-,26+,27?/m1/s1
|
||||
| InChIKey |
GXENQLUSOCKXDN-JZGSEIKYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.